Myriad Genetics Inc announces the launch of PROLARIS, a 46-gene prognostic test which quantitatively determines the risk of recurrence in patients who have undergone prostatectomy surgery.
Read MoreSpecific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients with pancreatic cancer, according to a new study.
Read More
An interview with Keith Chaitoff, Divisional Vice President, US Marketing
Read MoreBioImagene announces a collaboration with the University of Pennsylvania School of Medicine and Rutgers, the state university of New Jersey to develop Companion Algorithms for next generation companion diagnostics for digital pathology.
Read MoreChina Medical Technologies Inc, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe from the State Food and Drug Administration of China (SFDA).
Read More